ID   BMR1B_HUMAN             Reviewed;         502 AA.
AC   O00238; B2R953; P78366;
DT   30-MAY-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1997, sequence version 1.
DT   02-NOV-2010, entry version 114.
DE   RecName: Full=Bone morphogenetic protein receptor type-1B;
DE            Short=BMP type-1B receptor;
DE            Short=BMPR-1B;
DE            EC=2.7.11.30;
DE   AltName: CD_antigen=CDw293;
DE   Flags: Precursor;
GN   Name=BMPR1B;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Prostate;
RX   MEDLINE=97322244; PubMed=9178898; DOI=10.1038/sj.onc.1200964;
RA   Ide H., Katoh M., Sasaki H., Yoshida T., Aoki K., Nawa Y., Osada Y.,
RA   Sugimura T., Terada M.;
RT   "Cloning of human bone morphogenetic protein type IB receptor (BMPR-
RT   IB) and its expression in prostate cancer in comparison with other
RT   BMPRs.";
RL   Oncogene 14:1377-1382(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Ovary;
RX   MEDLINE=99160473; PubMed=10051328; DOI=10.1007/s003359900990;
RA   Astroem A.-K., Jin D.F., Imamura T., Roijer E., Rosenzweig B.,
RA   Miyazono K., ten Dijke P., Stenman G.;
RT   "Chromosomal localization of three human genes encoding bone
RT   morphogenetic protein receptors.";
RL   Mamm. Genome 10:299-302(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Uterus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=PNS;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   VARIANTS BDA2 LYS-200 AND TRP-486.
RX   PubMed=14523231; DOI=10.1073/pnas.2133476100;
RA   Lehmann K., Seemann P., Stricker S., Sammar M., Meyer B., Suering K.,
RA   Majewski F., Tinschert S., Grzeschik K.-H., Mueller D., Knaus P.,
RA   Nuernberg P., Mundlos S.;
RT   "Mutations in bone morphogenetic protein receptor 1B cause
RT   brachydactyly type A2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:12277-12282(2003).
RN   [7]
RP   INVOLVEMENT IN AMDGA.
RX   PubMed=15805157; DOI=10.1136/jmg.2004.023564;
RA   Demirhan O., Tuerkmen S., Schwabe G.C., Soyupak S., Akguel E.,
RA   Tastemir D., Karahan D., Mundlos S., Lehmann K.;
RT   "A homozygous BMPR1B mutation causes a new subtype of acromesomelic
RT   chondrodysplasia with genital anomalies.";
RL   J. Med. Genet. 42:314-317(2005).
RN   [8]
RP   VARIANT BRACHYDACTYLY TYPE C/BDA2 GLN-486.
RX   PubMed=16957682; DOI=10.1038/sj.ejhg.5201708;
RA   Lehmann K., Seemann P., Boergermann J., Morin G., Reif S., Knaus P.,
RA   Mundlos S.;
RT   "A novel R486Q mutation in BMPR1B resulting in either a brachydactyly
RT   type C/symphalangism-like phenotype or brachydactyly type A2.";
RL   Eur. J. Hum. Genet. 14:1248-1254(2006).
RN   [9]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-31; TRP-149; HIS-224; ASN-297 AND
RP   GLN-371.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: On ligand binding, forms a receptor complex consisting
CC       of two type II and two type I transmembrane serine/threonine
CC       kinases. Type II receptors phosphorylate and activate type I
CC       receptors which autophosphorylate, then bind and activate SMAD
CC       transcriptional regulators. Receptor for BMPS/OP-1.
CC   -!- CATALYTIC ACTIVITY: ATP + [receptor-protein] = ADP + [receptor-
CC       protein] phosphate.
CC   -!- COFACTOR: Magnesium or manganese (By similarity).
CC   -!- SUBCELLULAR LOCATION: Membrane; Single-pass type I membrane
CC       protein.
CC   -!- DISEASE: Defects in BMPR1B are the cause of acromesomelic
CC       chondrodysplasia with genital anomalies (AMDGA) [MIM:609441].
CC       Acromesomelic chondrodysplasias are rare hereditary skeletal
CC       disorders characterized by short stature, very short limbs, and
CC       hand/foot malformations. The severity of limb abnormalities
CC       increases from proximal to distal with profoundly affected hands
CC       and feet showing brachydactyly and/or rudimentary fingers (knob-
CC       like fingers).
CC   -!- DISEASE: Defects in BMPR1B are a cause of brachydactyly type A2
CC       (BDA2) [MIM:112600]. Brachydactylies (BDs) are a group of
CC       inherited malformations characterized by shortening of the digits
CC       due to abnormal development of the phalanges and/or the
CC       metacarpals. They have been classified on an anatomic and genetic
CC       basis into five groups, A to E, including three subgroups (A1 to
CC       A3) that usually manifest as autosomal dominant traits. BDA2 was
CC       described first in a large Norwegian kindred. BDA2 is caused by
CC       mutations in BMPR1B gene and studies demonstrate that these
CC       mutations function as dominant negatives in vitro and in vivo.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. TGFB receptor subfamily.
CC   -!- SIMILARITY: Contains 1 GS domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- WEB RESOURCE: Name=GeneReviews;
CC       URL="http://www.ncbi.nlm.nih.gov/sites/GeneTests/lab/gene/BMPR1B";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; D89675; BAA19765.1; -; mRNA.
DR   EMBL; U89326; AAC28131.1; -; mRNA.
DR   EMBL; AK313642; BAG36400.1; -; mRNA.
DR   EMBL; CH471057; EAX06060.1; -; Genomic_DNA.
DR   EMBL; BC047773; AAH47773.1; -; mRNA.
DR   EMBL; BC069796; AAH69796.1; -; mRNA.
DR   EMBL; BC069803; AAH69803.1; -; mRNA.
DR   IPI; IPI00939250; -.
DR   RefSeq; NP_001194.1; -.
DR   UniGene; Hs.598475; -.
DR   PDB; 3MDY; X-ray; 2.05 A; A/C=168-502.
DR   PDBsum; 3MDY; -.
DR   ProteinModelPortal; O00238; -.
DR   SMR; O00238; 30-113, 170-498.
DR   MINT; MINT-1340235; -.
DR   STRING; O00238; -.
DR   PRIDE; O00238; -.
DR   Ensembl; ENST00000264568; ENSP00000264568; ENSG00000138696.
DR   Ensembl; ENST00000394931; ENSP00000378389; ENSG00000138696.
DR   Ensembl; ENST00000440890; ENSP00000401907; ENSG00000138696.
DR   GeneID; 658; -.
DR   KEGG; hsa:658; -.
DR   UCSC; uc003htm.2; human.
DR   CTD; 658; -.
DR   GeneCards; GC04P095679; -.
DR   H-InvDB; HIX0024604; -.
DR   HGNC; HGNC:1077; BMPR1B.
DR   HPA; CAB009634; -.
DR   MIM; 112600; phenotype.
DR   MIM; 603248; gene.
DR   MIM; 609441; phenotype.
DR   Orphanet; 93396; Brachydactyly type A2.
DR   Orphanet; 93384; Brachydactyly type C.
DR   PharmGKB; PA25387; -.
DR   eggNOG; prNOG13312; -.
DR   HOVERGEN; HBG054502; -.
DR   InParanoid; O00238; -.
DR   OrthoDB; EOG9JHG1D; -.
DR   PhylomeDB; O00238; -.
DR   BRENDA; 2.7.10.2; 247.
DR   BRENDA; 2.7.11.30; 247.
DR   Pathway_Interaction_DB; bmppathway; BMP receptor signaling.
DR   Reactome; REACT_12034; Signaling by BMP.
DR   NextBio; 2676; -.
DR   ArrayExpress; O00238; -.
DR   Bgee; O00238; -.
DR   CleanEx; HS_BMPR1B; -.
DR   Genevestigator; O00238; -.
DR   GermOnline; ENSG00000138696; Homo sapiens.
DR   GO; GO:0005887; C:integral to plasma membrane; IC:UniProtKB.
DR   GO; GO:0043235; C:receptor complex; TAS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IDA:HGNC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046332; F:SMAD binding; IDA:HGNC.
DR   GO; GO:0030509; P:BMP signaling pathway; NAS:UniProtKB.
DR   GO; GO:0001502; P:cartilage condensation; NAS:UniProtKB.
DR   GO; GO:0035108; P:limb morphogenesis; IMP:UniProtKB.
DR   GO; GO:0001550; P:ovarian cumulus expansion; ISS:UniProtKB.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; IMP:BHF-UCL.
DR   GO; GO:0045669; P:positive regulation of osteoblast different...; IMP:BHF-UCL.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IDA:HGNC.
DR   InterPro; IPR000333; Activin_II_recpt.
DR   InterPro; IPR000472; Activin_rcpt.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR003605; TGF_beta_rcpt_GS.
DR   Pfam; PF01064; Activin_recp; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   Pfam; PF08515; TGF_beta_GS; 1.
DR   PRINTS; PR00653; ACTIVIN2R.
DR   SMART; SM00467; GS; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS51256; GS; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Disease mutation;
KW   Kinase; Magnesium; Manganese; Membrane; Metal-binding;
KW   Nucleotide-binding; Polymorphism; Receptor;
KW   Serine/threonine-protein kinase; Signal; Transferase; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL        1     13       Potential.
FT   CHAIN        14    502       Bone morphogenetic protein receptor type-
FT                                1B.
FT                                /FTId=PRO_0000024412.
FT   TOPO_DOM     14    126       Extracellular (Potential).
FT   TRANSMEM    127    148       Helical; (Potential).
FT   TOPO_DOM    149    502       Cytoplasmic (Potential).
FT   DOMAIN      174    203       GS.
FT   DOMAIN      204    494       Protein kinase.
FT   NP_BIND     210    218       ATP (By similarity).
FT   ACT_SITE    332    332       Proton acceptor (By similarity).
FT   BINDING     231    231       ATP (By similarity).
FT   VARIANT      31     31       R -> H (in a gastric adenocarcinoma
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041401.
FT   VARIANT     149    149       R -> W (in dbSNP:rs34231464).
FT                                /FTId=VAR_041402.
FT   VARIANT     200    200       I -> K (in BDA2; dbSNP:rs28939703).
FT                                /FTId=VAR_023819.
FT   VARIANT     224    224       R -> H (in dbSNP:rs35973133).
FT                                /FTId=VAR_041403.
FT   VARIANT     297    297       D -> N (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041404.
FT   VARIANT     371    371       R -> Q (in dbSNP:rs34970181).
FT                                /FTId=VAR_041405.
FT   VARIANT     486    486       R -> Q (in brachydactyly type C and BDA2;
FT                                with also additional features of
FT                                symphalangism-1).
FT                                /FTId=VAR_037967.
FT   VARIANT     486    486       R -> W (in BDA2; dbSNP:rs28939704).
FT                                /FTId=VAR_023820.
SQ   SEQUENCE   502 AA;  56930 MW;  B283D9BF45535C79 CRC64;
     MLLRSAGKLN VGTKKEDGES TAPTPRPKVL RCKCHHHCPE DSVNNICSTD GYCFTMIEED
     DSGLPVVTSG CLGLEGSDFQ CRDTPIPHQR RSIECCTERN ECNKDLHPTL PPLKNRDFVD
     GPIHHRALLI SVTVCSLLLV LIILFCYFRY KRQETRPRYS IGLEQDETYI PPGESLRDLI
     EQSQSSGSGS GLPLLVQRTI AKQIQMVKQI GKGRYGEVWM GKWRGEKVAV KVFFTTEEAS
     WFRETEIYQT VLMRHENILG FIAADIKGTG SWTQLYLITD YHENGSLYDY LKSTTLDAKS
     MLKLAYSSVS GLCHLHTEIF STQGKPAIAH RDLKSKNILV KKNGTCCIAD LGLAVKFISD
     TNEVDIPPNT RVGTKRYMPP EVLDESLNRN HFQSYIMADM YSFGLILWEV ARRCVSGGIV
     EEYQLPYHDL VPSDPSYEDM REIVCIKKLR PSFPNRWSSD ECLRQMGKLM TECWAHNPAS
     RLTALRVKKT LAKMSESQDI KL
//
